EDIT
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Dec 2024)
What this means for you
This application is over — abandoned 16 Dec 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97638305
- Mark type
- Stylized text
- Filed
- 19 Oct 2022
- Published for opposition
- 19 Sept 2023
- Abandoned
- 16 Dec 2024
- Attorney of record
- RACHELLE A. DUBOW
Goods and services
- Class 001 — Chemicals: Reagents for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; nucleic acids for laboratory use for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modifications for use in the fields of scientific research, clinical research, and scientific diagnostics research, namely, nucleic acids for laboratory use
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of genetically driven disorders, neurological, gastrointestinal, metabolic, immunological, dyslipidemias musculoskeletal, oncological disorders and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; reagents for medical and veterinary purposes being medical use; nucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acid vectors comprising nucleotides for medical and veterinary purposes, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes
Owner
- Saliogen Therapeutics, Inc., Lexington, MA, US
- Saliogen Therapeutics, Inc., Lexington, MA, US
Prosecution history
- 16 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Dec 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 08 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2024 — SOU EXTENSION 1 GRANTED
- 07 May 2024 — SOU EXTENSION 1 FILED
- 07 May 2024 — SOU TEAS EXTENSION RECEIVED
- 28 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Feb 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Feb 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 14 Nov 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Oct 2023 — EXPARTE APPEAL TERMINATED
- 26 Oct 2023 — EXPARTE APPEAL DISMISSED AS MOOT
- 19 Sept 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Sept 2023 — PUBLISHED FOR OPPOSITION
- 30 Aug 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED